UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 77

Sortiert nach

Medulloblastoma: an Old Diagnosis with New Promises

Current oncology reports, 2020-09, Vol.22 (9), p.90-90, Article 90

2020

Volltextzugriff (PDF)

Leptomeningeal dissemination in pediatric brain tumors

Neoplasia (New York, N.Y.), 2023-05, Vol.39, p.100898-100898, Article 100898

2023

Volltextzugriff (PDF)

Focused ultrasound-mediated blood-brain barrier opening is safe and feasible with moderately hypofractionated radiotherapy for brainstem diffuse midline glioma

Journal of translational medicine, 2024-03, Vol.22 (1), p.320-13, Article 320

2024

Volltextzugriff (PDF)

Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases

Proceedings of the National Academy of Sciences - PNAS, 2012-01, Vol.109 (5), p.1655-1660

2012

Volltextzugriff (PDF)

Neurological reflexes and early motor behavior in rats subjected to neonatal hypoxic–ischemic injury

Behavioural brain research, 2005-02, Vol.157 (1), p.157-165

2005

Volltextzugriff (PDF)

Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia

Proceedings of the National Academy of Sciences - PNAS, 2011-03, Vol.108 (9), p.3755-3760

2011

Volltextzugriff (PDF)

Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125

BMC cancer, 2014-11, Vol.14 (1), p.847-847, Article 847

2014

Volltextzugriff (PDF)

Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist

Proceedings of the National Academy of Sciences - PNAS, 2013-02, Vol.110 (7), p.2617-2622

2013

Volltextzugriff (PDF)

53 Inducing immune response with FLASH and conventional radiation in diffuse midline glioma (DMG)

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A62-A62

2023

Volltextzugriff (PDF)

Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonists

Proceedings of the National Academy of Sciences - PNAS, 2014-01, Vol.111 (2), p.781-786

2014

Volltextzugriff (PDF)

Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers

Cell cycle (Georgetown, Tex.), 2012-07, Vol.11 (13), p.2518-2525

2012

Volltextzugriff (PDF)

GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer

Cell cycle (Georgetown, Tex.), 2012-11, Vol.11 (22), p.4203-4210

2012

Volltextzugriff (PDF)

Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson’s disease

Behavioural brain research, 2004-05, Vol.151 (1), p.303-312

2004

Volltextzugriff (PDF)

A correlation of endocrine and anticancer effects of some antagonists of GHRH

Peptides (New York, N.Y. : 1980), 2010-10, Vol.31 (10), p.1839-1846

2010

Volltextzugriff (PDF)

GHRH antagonist causes DNA damage leading to p21 mediated cell cycle arrest and apoptosis in human colon cancer cells

Cell cycle (Georgetown, Tex.), 2009-10, Vol.8 (19), p.3149-3156

2009

Volltextzugriff (PDF)

Next-generation sequencing of cerebrospinal fluid for clinical molecular diagnostics in pediatric, adolescent and young adult brain tumor patients

Neuro-oncology (Charlottesville, Va.), 2022-10, Vol.24 (10), p.1763-1772

2022

Volltextzugriff (PDF)

RADT-09. IMMUNE RESPONSE IN DIFFUSE MIDLINE GLIOMA (DMG) FOLLOWING FLASH OR CONVENTIONAL RADIATION

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

SURG-07. A PHASE I STUDY EXAMINING THE FEASIBILITY OF INTERMITTENT CONVECTION-ENHANCED DELIVERY (CED) OF MTX110 FOR THE TREATMENT OF CHILDREN WITH NEWLY DIAGNOSED DIFFUSE MIDLINE GLIOMAS

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

DIPG-93. OVERALL EXPERIENCE OF TWO PHASE I CLINICAL TRIALS WITH FOCUSED ULTRASOUND-MEDIATED BLOOD BRAIN BARRIER OPENING IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH PROGRESSIVE DIPG/DMG USING A NEURONAVIGATION-BASED DEVICE

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

EPID-07. Outcome disparities in children, adolescents and young adults with medulloblastoma: A population-based analysis

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i48-i48

2022

Volltextzugriff (PDF)

MODL-09. FEASIBILITY OF ACUTE SLICE CULTURE-SINGLE CELL SEQUENCING DRUG SCREENING AS A TOOL TO SELECT THERAPY FOR CHILDREN WITH RELAPSED BRAIN TUMORS

Neuro-oncology (Charlottesville, Va.), 2020-12, Vol.22 (Supplement_3), p.iii412-iii413

2020

Volltextzugriff (PDF)

SURG-06. ENHANCED DELIVERY OF ANTI-PD1 FOR TREATMENT OF DIFFUSE MIDLINE GLIOMA USING FOCUSED ULTRASOUND-MEDIATED BLOOD-BRAIN BARRIER OPENING

Neuro-oncology (Charlottesville, Va.), 2023-06, Vol.25 (Supplement_1), p.i73-i73

2023

Volltextzugriff (PDF)

Immune Response following FLASH and Conventional Radiation in Diffuse Midline Glioma

International journal of radiation oncology, biology, physics, 2024-07, Vol.119 (4), p.1248-1260

2024

Volltextzugriff (PDF)

Effects of PACAP on in vitro and in vivo neuronal cell death, platelet aggregation, and production of reactive oxygen radicals

Regulatory peptides, 2004-12, Vol.123 (1-3), p.51-59

2004

Volltextzugriff (PDF)

DIPG-57. A systems biology approach to defining and targeting master regulator dependencies from bulk and single-Cell RNA-seq in diffuse midline glioma (DMG)

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i31-i32

2022

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(71)

Publikationsform

Artikel
(76)
Buchkapitel
(1)

Sprache

Englisch
(77)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Life Sciences & Biomedicine
(38)
Animals
(34)
Humans
(31)
Mice
(21)
Male
(20)
Mice, Nude
(18)
Oncology
(18)
Cell Line, Tumor
(16)
Rats
(15)
Targeted Therapy
(15)
Growth Hormone-Releasing Hormone - Antagonists & Inhibitors
(14)
Biological And Medical Sciences
(12)
Female
(12)
Cell Biology
(10)
Sermorelin - Analogs & Derivatives
(10)
Tumors
(10)
Xenograft Model Antitumor Assays
(10)
Endocrinology & Metabolism
(9)
Gonadotropin-Releasing Hormone - Analogs & Derivatives
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Medulloblastoma: an Old Diagnosis with New Promises

Leptomeningeal dissemination in pediatric brain tumors

Focused ultrasound-mediated blood-brain barrier opening is safe and feasible with moderately hypofractionated radiotherapy for brainstem diffuse midline glioma

Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases

Neurological reflexes and early motor behavior in rats subjected to neonatal hypoxic–ischemic injury

Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia

Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125

Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist

53 Inducing immune response with FLASH and conventional radiation in diffuse midline glioma (DMG)

Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonists

Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers

GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer

Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson’s disease

A correlation of endocrine and anticancer effects of some antagonists of GHRH

GHRH antagonist causes DNA damage leading to p21 mediated cell cycle arrest and apoptosis in human colon cancer cells

Next-generation sequencing of cerebrospinal fluid for clinical molecular diagnostics in pediatric, adolescent and young adult brain tumor patients

RADT-09. IMMUNE RESPONSE IN DIFFUSE MIDLINE GLIOMA (DMG) FOLLOWING FLASH OR CONVENTIONAL RADIATION

SURG-07. A PHASE I STUDY EXAMINING THE FEASIBILITY OF INTERMITTENT CONVECTION-ENHANCED DELIVERY (CED) OF MTX110 FOR THE TREATMENT OF CHILDREN WITH NEWLY DIAGNOSED DIFFUSE MIDLINE GLIOMAS

DIPG-93. OVERALL EXPERIENCE OF TWO PHASE I CLINICAL TRIALS WITH FOCUSED ULTRASOUND-MEDIATED BLOOD BRAIN BARRIER OPENING IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH PROGRESSIVE DIPG/DMG USING A NEURONAVIGATION-BASED DEVICE

EPID-07. Outcome disparities in children, adolescents and young adults with medulloblastoma: A population-based analysis

MODL-09. FEASIBILITY OF ACUTE SLICE CULTURE-SINGLE CELL SEQUENCING DRUG SCREENING AS A TOOL TO SELECT THERAPY FOR CHILDREN WITH RELAPSED BRAIN TUMORS

SURG-06. ENHANCED DELIVERY OF ANTI-PD1 FOR TREATMENT OF DIFFUSE MIDLINE GLIOMA USING FOCUSED ULTRASOUND-MEDIATED BLOOD-BRAIN BARRIER OPENING

Immune Response following FLASH and Conventional Radiation in Diffuse Midline Glioma

Effects of PACAP on in vitro and in vivo neuronal cell death, platelet aggregation, and production of reactive oxygen radicals

DIPG-57. A systems biology approach to defining and targeting master regulator dependencies from bulk and single-Cell RNA-seq in diffuse midline glioma (DMG)

Suchergebnisse filtern